SERB Pharmaceuticals

We are a growing pharmaceutical company and a dedicated ally to healthcare providers treating patients facing rare diseases and emergencies.
Rare Emergency Medicine: SERB has the broadest antidote portfolio in the world, including medical countermeasures for chemical, biological, radiological and nuclear (CBRN) risks. This makes us a trusted partner and one-stop-shop for hospitals, healthcare systems, first responders, emergency preparedness agencies, and non-profit organisations.

Rare Diseases: Our growing portfolio helps patients with rare conditions in oncology, rare neurologic syndromes, and rare metabolic disorders. We work to help these patients get the diagnosis they need and access to the treatment options they deserve. This “patient first” culture has helped us to build long-term relationships with patient groups and key opinion leaders.

An end-to-end platform
We are a fully integrated pharmaceutical company, but we remain agile and entrepreneurial.

Our goal is to optimise every stage of the pharma value chain through a perfect balance of in-house capabilities and closely managed external partners. Our unique industry expertise allows us to determine what to do ourselves and what to outsource to trusted partners. This allows us to efficiently acquire, develop, manufacture, launch and commercialize specialist medicines, and consistently supply them worldwide.